Evidence map›Paper›PMID 35295534›Full record

ArticleFrontiers in pain research (Lausanne, Switzerland)2021

The Use of Conditioning Open-Label Placebo in Opioid Dose Reduction: A Case Report and Literature Review.

Maria A Estudillo-Guerra, Ines Mesia-Toledo, Jeffrey C Schneider, Leon Morales-Quezada

Registry-linked trialOpen access · goldAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in pain research (Lausanne, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06350786 (Conditioned Open-label Placebos to Facilitate Opioid Reduction in Patients With Subacute or Chronic Pain Pain), which is not on this map. Cited by 1 paper, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed, 1 pooled it
–field-weighted citation impact, top 93% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06350786 narecruitingnot on this mapstarted 2024, after this paper: background citation

Conditioned Open-label Placebos to Facilitate Opioid Reduction in Patients With Subacute or Chronic Pain Pain: a Randomized Controlled Trial

TypeinterventionalSponsorCosima LocherRan2024 to 2026Enrolled86ConditionsChronic Pain, Subacute PainArmsP-Dragees blue Lichtenstein, Placebo dragees, Control group (EM)
3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 synthesis or guideline pooled it, 2 citations in OpenAlex.

  1. Pooled it
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Maria A Estudillo-GuerraDepartment of Physical Medicine and Rehabilitation, Harvard Medical School, Spaulding Research Institute, Spaulding Rehabilitation Hospital, Boston, MA, United States.
Ines Mesia-ToledoDepartment of Physical Medicine and Rehabilitation, Harvard Medical School, Spaulding Research Institute, Spaulding Rehabilitation Hospital, Boston, MA, United States.
Jeffrey C SchneiderDepartment of Physical Medicine and Rehabilitation, Harvard Medical School, Spaulding Research Institute, Spaulding Rehabilitation Hospital, Boston, MA, United States.
Leon Morales-QuezadaDepartment of Physical Medicine and Rehabilitation, Harvard Medical School, Spaulding Research Institute, Spaulding Rehabilitation Hospital, Boston, MA, United States.
Harvard University · USSpaulding Rehabilitation Hospital · US

Funding

Opioid Dose Reduction in Comprehensive Inpatient Rehabilitation: A pharmaco-behavioral approachK23DA052041 · NIDA · SPAULDING REHABILITATION HOSPITAL · PI MORALES-QUEZADA, JORGE LEON · 2021 to 2025
$784k
NIDA NIH HHS K23 DA052041
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

conditioningopen-label placeboopioidspainpharmaco-behavioral

Identifiers

PMID35295534
PMCPMC8915754
OpenAlexW3181057834

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.